A mitotic inhibitor - It slows the growth of cancer cells
FDA Alerts
Administration Warnings
For IV use only.
Fatal if given intrathecally. (See Intrathecal Administration under Cautions.)
Extremely important to properly place IV needle or catheter before any vincristine is injected.
Leakage into surrounding tissues may cause considerable irritation.
Discontinue immediately if leakage occurs; administer remainder of the dose through another vein.
Local treatment of leakage area (e.g., with hyaluronidase injection, application of moderate heat) may help disperse vincristine and minimize discomfort and possibility of cellulitis.
Limit to Qualified Personnel
For administration only by individuals experienced in the administration of vincristine.
This drug is given as an infusion into a vein. It is administered in a hospital or clinic by a specially trained health care professional. If you have pain, swelling, burning, or any unusual feeling around the site of your injection, tell your health care professional right away.
Talk to your pediatrician regarding the use of this medicine in children. While this drug may be prescribed for selected conditions, precautions do apply.
Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once.
NOTE: This medicine is only for you. Do not share this medicine with others.
What if I miss a dose?
It is important not to miss your dose. Call your doctor or health care professional if you are unable to keep an appointment.
What may interact with this medicine?
Do not take this medicine with any of the following medications:
This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.
FDA Alerts
Drug Info Tools
